The store will not work correctly when cookies are disabled.
1-methyl-1-(3,4,5-trimethoxybenzyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline hydrochloride
ID: ALA3275923
PubChem CID: 12380061
Max Phase: Preclinical
Molecular Formula: C20H26ClNO5
Molecular Weight: 359.42
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: COc1cc(CC2(C)NCCc3cc(O)c(O)cc32)cc(OC)c1OC.Cl
Standard InChI: InChI=1S/C20H25NO5.ClH/c1-20(14-10-16(23)15(22)9-13(14)5-6-21-20)11-12-7-17(24-2)19(26-4)18(8-12)25-3;/h7-10,21-23H,5-6,11H2,1-4H3;1H
Standard InChI Key: SRTUXJRQBMMXTJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 28 0 0 0 0 0 0 0 0999 V2000
16.3120 -0.4447 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
7.2736 -1.2958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2724 -2.1232 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9872 -2.5360 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9854 -0.8830 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7008 -1.2922 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7042 -2.1206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4194 -2.5297 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1358 -2.1148 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.1324 -1.2863 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4126 -0.8727 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5590 -0.8835 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.5576 -2.5351 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.4217 -3.3547 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1373 -3.7652 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1370 -4.5886 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8517 -4.9991 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5660 -4.5846 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5611 -3.7553 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8458 -3.3486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2822 -4.9942 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.8535 -5.8241 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.2730 -3.3384 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.1400 -6.2382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9900 -3.7464 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2855 -5.8192 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7000 -2.9375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3 4 1 0
8 14 1 0
4 7 2 0
14 15 1 0
2 3 2 0
15 16 2 0
6 5 2 0
16 17 1 0
5 2 1 0
17 18 2 0
6 11 1 0
18 19 1 0
7 8 1 0
19 20 2 0
20 15 1 0
8 9 1 0
18 21 1 0
9 10 1 0
17 22 1 0
10 11 1 0
19 23 1 0
6 7 1 0
22 24 1 0
2 12 1 0
23 25 1 0
21 26 1 0
3 13 1 0
8 27 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 359.42 | Molecular Weight (Monoisotopic): 359.1733 | AlogP: 2.73 | #Rotatable Bonds: 5 |
Polar Surface Area: 80.18 | Molecular Species: BASE | HBA: 6 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.54 | CX Basic pKa: 8.58 | CX LogP: 2.49 | CX LogD: 1.51 |
Aromatic Rings: 2 | Heavy Atoms: 26 | QED Weighted: 0.71 | Np Likeness Score: 0.87 |
References
1. Miller DD, Osei-Gyimah P, Raman RV, Feller DR.. (1977) Synthesis of 1-substituted analogues of trimetoquinol possessing differential and selective beta-adrenergic properties., 20 (11): [PMID:21293] [10.1021/jm00221a029] |